Rearrangement and allelic imbalance on chromosome 5 leads to homozygous deletions in the CDKN2A/2B tumor suppressor gene region in rat endometrial cancer

Cancer Genetics and Cytogenetics

Volumn 184, Issue 1, 2008, Pages 9-21

  Adamovic, Tatjana ^a   Hamta, Ahmad ^b   Roshani, Leyla ^b   Lü, Xuchun ^b   Röhme, Dan ^b   Helou, Khalil ^b   Klinga Levan, Karin ^c   Levan, Göran ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF SKÖVDE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B;

ALLELIC IMBALANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CHROMOSOME 5; CHROMOSOME ABERRATION; CHROMOSOME BAND; CHROMOSOME PAINTING; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; EXON; FEMALE; GENE DELETION; GENE REARRANGEMENT; HETEROZYGOSITY LOSS; MARKER GENE; METAPHASE; MICROSATELLITE MARKER; MOLECULAR PROBE; NONHUMAN; POLYMERASE CHAIN REACTION; POLYMORPHIC LOCUS; PRIORITY JOURNAL; RAT; TUMOR CELL; TUMOR SUPPRESSOR GENE;

ALLELES; ANIMALS; BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOME PAINTING; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DNA PRIMERS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE DELETION; GENE ORDER; GENES, P16; HOMOZYGOTE; IN SITU HYBRIDIZATION, FLUORESCENCE; POLYMERASE CHAIN REACTION; RATS;

RATTUS;

EID: 44949156448     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.02.016     Document Type: Article

References (45)

1. Cavanagh D., Fiorica J.V., Hoffman M.S., Durfee J., and Nicosia S.V. Adenocarcinoma of the endometrium: an institutional review. Cancer Control 6 (1999) 354-360
2. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
3. Deerberg F., and Kaspareit J. Endometrial carcinoma in BDII/Han rats: model of a spontaneous hormone-dependent tumor. J Natl Cancer Inst 78 (1987) 1245-1251
4. Kaspareit-Rittinghausen J., Deerberg F., and Rapp K. Mortality and incidence of spontaneous neoplasms in BDII/Han rats. Z Versuchstierkd 30 (1987) 209-216
5. Helou K., Walentinsson A., Beckmann B., Johansson A., Hedrich H.J., Szpirer C., Klinga-Levan K., and Levan G. Analysis of genetic changes in rat endometrial carcinomas by means of comparative genomic hybridization. Cancer Genet Cytogenet 127 (2001) 118-127
6. Hamta A., Adamovic T., Helou K., and Levan G. Cytogenetic aberrations in spontaneous endometrial adenocarcinomas in the BDII rat model as revealed by chromosome banding and comparative genome hybridization. Cancer Genet Cytogenet 159 (2005) 123-128
7. Kamb A., Gruis N.A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S.V., Stockert E., Day III R.S., Johnson B.E., and Skolnick M.H. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264 (1994) 436-440
8. Nobori T., Miura K., Wu D.J., Lois A., Takabayashi K., and Carson D. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368 (1994) 753-756
9. Roshani L., Wedekind D., Szpirer J., Taib Z., Szpirer C., Beckmann B., Rivière M., Hedrich H.J., and Klinga-Levan K. Genetic identification of multiple susceptibility genes involved in the development of endometrial carcinoma in a rat model. Int J Cancer 94 (2001) 795-799
10. Roshani L., Mallon P., Sjostrand E., Wedekind D., Szpirer J., Szpirer C., Hedrich H.J., and Klinga-Levan K. Genetic analysis of susceptibility to endometrial adenocarcinoma in the BDII rat model. Cancer Genet Cytogenet 158 (2005) 137-141
11. Islam M.Q., and Levan G. A new fixation procedure for improved quality G-bands in routine cytogenetic work. Hereditas 107 (1987) 127-130
12. Pinkel D., Landegent J., Collins C., Fuscose J., Segraves R., Lucas J., and Gray J. Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc Natl Acad Sci U S A 85 (1988) 9138-9142
13. Walentinsson A., Sjöling A., Helou K., Klinga-Levan K., and Levan G. Genomewide assessment of genetic alterations in DMBA-induced rat sarcomas: cytogenetic, CGH, and allelotype analyses reveal recurrent DNA copy number changes in rat chromosomes 1, 2, 4, and 7. Genes Chromosomes Cancer 28 (2000) 184-195
14. Nordlander C., Behboudi A., Levan G., and Klinga-Levan K. Allelic imbalance on chromosome 10 in rat endometrial adenocarcinomas. Cancer Genet Cytogenet 156 (2005) 158-166
15. Lü X.C. Anchorage independence in tumor cells: genomic structure and functional role of the Cdkn2a/2b tumor suppressor region in the rat. PhD dissertation (2003), Göteborg University, Göteborg, Sweden
16. Sherr C.J. The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2 (2001) 731-737
17. Zhu X., Dunn J.M., Goddard A.D., Squire J.A., Becker A., Phillips R.A., and Gallie B.L. Mechanisms of loss of heterozygosity in retinoblastoma. Cytogenet Cell Genet 59 (1992) 248-252
18. Sherr C.J. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 60 (2000) 3689-3695
19. Cairns P., Mao L., Merlo A., Lee D.J., Schwab D., Eby Y., Tokino K., van der Riet P., Blaugrund J.E., and Sidransky D. Rates of p16 (MTS1) mutations in primary tumours with 9p loss. Science 265 (1994) 415-417
20. Cairns P., Polascik T.J., Eby Y., Tokino K., Califano J., Merlo A., Mao L., Herath J., Jenkins R., Westra W., Rutter J.L., Buckler A., Gabrielson E., Tockman M., Cho K.R., Hedrick L., Bova G.S., Isaacs W., Koch W., Schwab D., and Sidransky D. Frequency of homozygous deletions at p16/CDKN2 in primary human tumours. Nat Genet 11 (1995) 210-212
21. INK4 in human cancer. Proc Natl Acad Sci U S A 91 (1994) 11045-11049
22. Reed A.L., Califano J., Cairns P., Westra W.H., Jones R.M., Koch W., Ahrendt S., Eby Y., Sewell D., Nawroz H., Bartek J., and Sidransky D. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 56 (1996) 3630-3633
23. Muscarella P., Melvin W.S., Fisher W.E., Foor J., Ellison E.C., Herman J.G., Schirmer W.J., Hitchcock C.L., DeYoung B.R., and Weghorst C.M. Genetic alterations in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors: an analysis of p16/MTS1 tumor suppressor gene inactivation. Cancer Res 58 (1998) 237-240
24. INK4B alterations in primary gynecologic malignancy. Gynecol Oncol 65 (1997) 319-324
25. Nakashima R., Fujita M., Enomoto T., Haba T., Yoshino K., Wada H., Kurachi H., Sasaki M., Wakasa K., Inoue M., Buzard G., and Murata Y. Alteration of p16 and p15 genes in human uterine tumors. Br J Cancer 80 (1999) 458-467
26. Milde-Langosch K., Riethdorf L., Bamberger A.-M., and Löning T. P16/MTS1 and pRB expression in endometrial carcinomas. Virchows Arch 434 (1999) 23-28
27. Yuan J.R., Fu S.B., Fu H., and Li P. Significance of methylation and abnormal expression of the p16 gene in endometrial carcinoma. [In Chinese]. Yi Chuan Xue Bao 31 (2004) 454-459
28. Hahn W.C., and Weinberg R.A. Modelling the molecular circuitry of cancer. Nat Rev Cancer 2 (2002) 331-341
29. Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413 (2001) 83-86
30. Sharpless N.E., Bardeesy N., Lee K.H., Carrasco D., Castrillon D.H., Aguirre A.J., Wu E.A., Horner J.W., and DePinho R.A. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413 (2001) 86-91
31. Sherr C.J. Parsing Ink4a/Arf: "pure" p16-null mice. Cell 106 (2001) 531-534
32. Yeager T.R., DeVries S., Jarrard D.F., Kao C., Nakada S.Y., Moon T.D., Bruskewitz R., Stadler W.M., Meisner L.F., Gilchrist K.W., Newton M.A., Waidman F.M., and Reznikoff C.A. Overcoming cellular senescence in human cancer pathogenesis. Genes Dev 12 (1998) 163-174
33. INK4a and pRb inactivation with immortalization of human cells. Carcinogenesis 23 (2002) 2111-2117
34. Lloyd R.V. Growth factors. Endocr Pathol 8 (1997) 121-127
35. INK4A. Cell Growth Differ 11 (2000) 373-384
36. INK4 deletions with monosomy five in kidney epithelial cell lines but not primary renal tumors. Cancer Res 55 (1995) 1607-1612
37. Serrano M., Lee H.-W., Chin L., Cordon-Cardo C., Beach D., and De Pinho R.A. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85 (1996) 27-37
38. INK4B in human somatic cell hybrids and hybrid-derived tumors. Cell Growth Differ 10 (1999) 27-33
39. Pantoja C., Palmero I., and Serrano M. Identification of the gene immediately downstream of the murine INK4a/ARF locus. Exp Gerontol 36 (2001) 1289-1302
40. cdkn2a/ARF, acts as a tumor suppressor in a breast cancer cell line. Cancer Res 62 (2002) 6639-6644
41. Ohta M., Berd D., Shimizu M., Nagai H., Cotticelli M.-G., Mastrangelo M., Shields J.A., Shields C.L., Croce C.M., and Huebner K. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma. Int J Cancer 65 (1996) 762-767
42. INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC). Oncogene 17 (1998) 2669-2675
43. Lydiatt W.M., Davidson B.J., Schantz S.P., Caruana S., and Chaganti R.S. 9p21 deletion correlates with recurrence in head and neck cancer. Head Neck 20 (1998) 113-118
44. INK4A and alterations of the 9p21-23 chromosome region in non-small-cell lung carcinomas: relationship with tumor growth parameters and ploidy status. Int J Cancer 89 (2000) 133-141
45. Raschke S., Balz V., Efferth T., Schulz W.A., and Florl A.R. Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines. Genes Chromosomes Cancer 42 (2005) 58-67